Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
grade B 28.76 0.81% 0.23
PETQ closed up 4.05 percent on Tuesday, November 20, 2018, on 83 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical PETQ trend table...

Date Alert Name Type % Chg
Nov 20 Crossed Above 200 DMA Bullish 0.81%
Nov 20 Lower Bollinger Band Walk Weakness 0.81%
Nov 20 Strong but Oversold Other 0.81%
Nov 20 Outside Day Range Expansion 0.81%
Nov 20 Lower Bollinger Band Touch Weakness 0.81%
Nov 20 Oversold Stochastic Weakness 0.81%
Nov 19 200 DMA Resistance Bearish 4.89%
Nov 19 Calm After Storm Range Contraction 4.89%
Nov 19 Lower Bollinger Band Walk Weakness 4.89%
Nov 19 Below Lower BB Weakness 4.89%

Older signals for PETQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Is PETQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 21 Factors of Influence in 2018, Key Indicators and Opportunity within Okta, One Horizon Group, Vivopower International Plc, PetIQ, Quanterix, and Eidos Therapeutics — New Research Emphasizes Economic Growth
Nov 14 PetIQ slides 6.1% post Q3 results
Nov 14 PetIQ (PETQ) CEO McCord Christensen on Q3 2018 Results - Earnings Call Transcript
Nov 13 PetIQ (PETQ) Beats Q3 Earnings and Revenue Estimates
Nov 13 PetIQ: 3Q Earnings Snapshot
Nov 13 PetIQ 2018 Q3 - Results - Earnings Call Slides
Nov 13 PetIQ misses by $0.06, beats on revenue
Nov 13 PetIQ, Inc. Reports Third Quarter 2018 Financial Results
Nov 13 Earnings Scheduled For November 13, 2018
Nov 9 Who Joins Square On This List Of Today's Fastest-Growing Companies?
See more PETQ news...
Indicators
Indicator Value
52 Week High 43.93
52 Week Low 17.56
Average Volume 666,827
200-Day Moving Average 27.7153
50-Day Moving Average 34.9726
20-Day Moving Average 31.337
10-Day Moving Average 30.71
Average True Range 2.1176
ADX 32.0
+DI 13.0901
-DI 29.7711
Chandelier Exit (Long, 3 ATRs ) 28.6272
Chandelier Exit (Short, 3 ATRs ) 33.1828
Upper Bollinger Band 35.5618
Lower Bollinger Band 27.1122
Percent B (%b) 0.17
BandWidth 26.963653
MACD Line -1.6491
MACD Signal Line -1.2824
MACD Histogram -0.3667
Fundamentals Value
Market Cap 377.25 Million
Num Shares 13.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 57.06
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.53
Resistance 3 (R3) 31.35 30.18 31.03
Resistance 2 (R2) 30.18 29.41 30.27 30.86
Resistance 1 (R1) 29.35 28.94 29.77 29.53 30.70
Pivot Point 28.18 28.18 28.38 28.27 28.18
Support 1 (S1) 27.35 27.41 27.77 27.53 26.36
Support 2 (S2) 26.18 26.94 26.27 26.20
Support 3 (S3) 25.35 26.18 26.03
Support 4 (S4) 25.53